Works about PACLITAXEL
Results: 5000
Tislelizumab combined with nab‐paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two‐cohort, phase 2 trial.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1429, doi. 10.1002/ijc.35261
- By:
- Publication type:
- Article
Integrated in silico‐in vitro profiling of the systematic response of paclitaxel and its analogues to clinical tubulin variations in gynecologic cancers: Implications for the molecular mechanism of acquired tumor chemoresistance.
- Published in:
- Journal of the Chinese Chemical Society, 2025, v. 72, n. 1, p. 14, doi. 10.1002/jccs.202400259
- By:
- Publication type:
- Article
Is a low dose of dexamethasone sufficient to prevent paclitaxel-related hypersensitivity reactions? A retrospective study in patients with gynecologic malignancy.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 525, doi. 10.1080/17512433.2024.2343852
- By:
- Publication type:
- Article
Protective Effect of Nerolidol on Paclitaxel‐Induced Reproductive Toxicity in Rats: Oxidative Stress and Inflammation.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2025, v. 136, n. 2, p. 1, doi. 10.1111/bcpt.14126
- By:
- Publication type:
- Article
Plasma‐Activated Hydrogel Synergies With Paclitaxel to Enhance the Anticancer Efficacy.
- Published in:
- Plasma Processes & Polymers, 2025, v. 22, n. 2, p. 1, doi. 10.1002/ppap.202400167
- By:
- Publication type:
- Article
Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer.
- Published in:
- Clinical Journal of Oncology Nursing, 2025, v. 29, n. 2, p. 151, doi. 10.1188/25.CJON.151-156
- By:
- Publication type:
- Article
Updating the Carboplatin Hypersensitivity Protocol: Two Case Studies.
- Published in:
- Clinical Journal of Oncology Nursing, 2025, v. 29, n. 2, p. E47, doi. 10.1188/25.CJON.E47-E51
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03989-0
- By:
- Publication type:
- Article
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae260
- By:
- Publication type:
- Article
Coaxially Electrocentrifugally Spun Ciprofloxacin/Paclitaxel‐Loaded Pullulan/PLGA Core/Sheath Nanofibers and Their In Vitro Cytotoxic Efficacy Toward Melanoma Cells.
- Published in:
- Journal of Applied Polymer Science, 2025, v. 142, n. 16, p. 1, doi. 10.1002/app.56759
- By:
- Publication type:
- Article
Ameliorative Potential of Carvedilol Versus Platelet-Rich Plasma Against Paclitaxel-Induced Femoral Neuropathy in Wistar Rats: A Light and Electron Microscopic Study.
- Published in:
- Microscopy & Microanalysis, 2025, v. 31, n. 1, p. 1, doi. 10.1093/mam/ozaf002
- By:
- Publication type:
- Article
Predictive factors of chemotherapy‑induced nausea and vomiting in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy: A retrospective study.
- Published in:
- Oncology Letters, 2025, v. 29, n. 4, p. N.PAG, doi. 10.3892/ol.2025.14913
- By:
- Publication type:
- Article
Carbon Nanodots as a Red Emissive Fluorescent Probe for the Super‐Resolution Microscopy of DNA Dynamics during Paclitaxel Treatment.
- Published in:
- Small Structures, 2025, v. 6, n. 3, p. 1, doi. 10.1002/sstr.202400571
- By:
- Publication type:
- Article
Seasonal Changes in Secondary Metabolites and Antioxidant Activity of Corylus avellana.
- Published in:
- International Journal of Horticultural Science & Technology, 2024, v. 12, n. 4, p. 1011, doi. 10.22059/ijhst.2024.370283.752
- By:
- Publication type:
- Article
Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant: A Case Report and Genomic Literature Review.
- Published in:
- In Vivo, 2025, v. 39, n. 2, p. 1173, doi. 10.21873/invivo.13921
- By:
- Publication type:
- Article
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells.
- Published in:
- OncoTargets & Therapy, 2025, v. 18, p. 179, doi. 10.2147/OTT.S485100
- By:
- Publication type:
- Article
Optimization of the poloxamer 407-conjugated gelatin to synthesize pH-sensitive nanocarriers for controlled paclitaxel delivery.
- Published in:
- Journal of Polymer Research, 2025, v. 32, n. 2, p. 1, doi. 10.1007/s10965-024-04248-1
- By:
- Publication type:
- Article
β-cyclodextrin inclusion complex as a potent delivery system for enhanced cytotoxicity of paclitaxel in triple-negative breast cancer cells.
- Published in:
- Journal of Nanoparticle Research, 2025, v. 27, n. 2, p. 1, doi. 10.1007/s11051-025-06229-x
- By:
- Publication type:
- Article
Microtubule-modulating drugs alter sensitivity to isoflurane in mice.
- Published in:
- BMC Anesthesiology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12871-025-02956-9
- By:
- Publication type:
- Article
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 2, p. e2461639, doi. 10.1001/jamanetworkopen.2024.61639
- By:
- Publication type:
- Article
Anti-Hyperalgesic Effect of Isopulegol Involves GABA and NMDA Receptors in a Paclitaxel-Induced Neuropathic Pain Model.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 256, doi. 10.3390/ph18020256
- By:
- Publication type:
- Article
Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer.
- Published in:
- Genes, 2025, v. 16, n. 2, p. 133, doi. 10.3390/genes16020133
- By:
- Publication type:
- Article
Taxane-Producing Fungi Isolated from Taxus globosa Tree Bark.
- Published in:
- Microorganisms, 2025, v. 13, n. 2, p. 300, doi. 10.3390/microorganisms13020300
- By:
- Publication type:
- Article
Development of heterocyclic-based anticancer agents: A comprehensive review.
- Published in:
- Heterocyclic Communications, 2025, v. 31, n. 1, p. 1, doi. 10.1515/hc-2022-0179
- By:
- Publication type:
- Article
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting.
- Published in:
- Wiener Klinische Wochenschrift, 2010, v. 122, n. 21/22, p. 649, doi. 10.1007/s00508-010-1483-1
- By:
- Publication type:
- Article
A Multi-Fluorescent MDA435 Cell Line for Mitosis Inhibitor Studies: Simultaneous Visualization of Chromatin, Microtubules, and Nuclear Envelope in Living Cells.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 10, p. 2603, doi. 10.1271/bbb.70355
- By:
- Publication type:
- Article
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 284, doi. 10.1111/vco.12976
- By:
- Publication type:
- Article
Antitumour effects of Liporaxel (oral paclitaxel) for canine melanoma in a mouse xenograft model.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 152, doi. 10.1111/vco.12540
- By:
- Publication type:
- Article
Evaluation of intravenous and subcutaneous administration of a novel, excipient‐free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 650, doi. 10.1111/vco.12435
- By:
- Publication type:
- Article
A dose-finding study with a novel water-soluble formulation of paclitaxel for the treatment of malignant high-grade solid tumours in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 4, p. 243, doi. 10.1111/j.1476-5829.2011.00314.x
- By:
- Publication type:
- Article
Evaluation of Intracavitary Chemotherapy Delivery for the Treatment of Mammary Carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 43, doi. 10.1111/j.1476-5810.2005.0064r.x
- By:
- Publication type:
- Article
The Synthesis and Properties of a New Carrier for Paclitaxel and Doxorubicin Based on the Amphiphilic Copolymer of N‐vinyl‐2‐pyrrolidone and Acrylic Acid.
- Published in:
- Macromolecular Chemistry & Physics, 2022, v. 223, n. 17, p. 1, doi. 10.1002/macp.202200081
- By:
- Publication type:
- Article
Encapsulation of Drug‐Loaded Graphene Oxide‐Based Nanocarrier into Electrospun Pullulan Nanofibers for Potential Local Chemotherapy of Breast Cancer.
- Published in:
- Macromolecular Chemistry & Physics, 2021, v. 222, n. 15, p. 1, doi. 10.1002/macp.202100096
- By:
- Publication type:
- Article
Amphiphilic Triblock Copolymers from Poly(2-oxazoline) with Different Hydrophobic Blocks: Changes of the Micellar Structures upon Addition of a Strongly Hydrophobic Cancer Drug.
- Published in:
- Macromolecular Chemistry & Physics, 2016, v. 217, n. 13, p. 1448, doi. 10.1002/macp.201500465
- By:
- Publication type:
- Article
A Cytochrome P450 Enzyme Catalyses Oxetane Ring Formation in Paclitaxel Biosynthesis.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 31, p. 1, doi. 10.1002/ange.202407070
- By:
- Publication type:
- Article
Coarse‐Grained Model‐Assisted Design of Polymer Prodrug Nanoparticles with Enhanced Cytotoxicity: A Combined Theoretical and Experimental Study.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 12, p. 1, doi. 10.1002/ange.202316056
- By:
- Publication type:
- Article
Heinz‐Günter Floss (1934–2022).
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 31, p. 1, doi. 10.1002/ange.202305459
- By:
- Publication type:
- Article
Total Synthesis of Taxol Enabled by Inter‐ and Intramolecular Radical Coupling Reactions.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 10, p. 1, doi. 10.1002/ange.202219114
- By:
- Publication type:
- Article
Antineoplastic Enzyme as Drug Carrier with Activatable Catalytic Activity for Efficient Combined Therapy.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 41, p. 1, doi. 10.1002/ange.202208583
- By:
- Publication type:
- Article
Exquisite Vesicular Nanomedicine by Paclitaxel Mediated Co‐assembly with Camptothecin Prodrug.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 38, p. 21201, doi. 10.1002/ange.202108658
- By:
- Publication type:
- Article
A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 51, p. 23398, doi. 10.1002/ange.202008732
- By:
- Publication type:
- Article
Carrier‐Free Delivery of Precise Drug–Chemogene Conjugates for Synergistic Treatment of Drug‐Resistant Cancer.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 41, p. 18100, doi. 10.1002/ange.202006895
- By:
- Publication type:
- Article
Comment on "Photo‐Controlled Reversible Microtubule Assembly Mediated by Paclitaxel‐Modified Cyclodextrin".
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 20, p. 7724, doi. 10.1002/ange.201912616
- By:
- Publication type:
- Article
Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye‐Labeled Cargo.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 12, p. 4708, doi. 10.1002/ange.201914120
- By:
- Publication type:
- Article
Expanding the Arsenal of Pt<sup>IV</sup> Anticancer Agents: Multi‐action Pt<sup>IV</sup> Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 50, p. 18386, doi. 10.1002/ange.201910014
- By:
- Publication type:
- Article
A Nanoemulsion with A Porphyrin Shell for Cancer Theranostics.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 42, p. 15116, doi. 10.1002/ange.201908664
- By:
- Publication type:
- Article
On-Chip Fabrication of Paclitaxel-Loaded Chitosan Nanoparticles for Cancer Therapeutics.
- Published in:
- Advanced Functional Materials, 2014, v. 24, n. 4, p. 432, doi. 10.1002/adfm.201301628
- By:
- Publication type:
- Article
Drug Delivery: On-Chip Fabrication of Paclitaxel-Loaded Chitosan Nanoparticles for Cancer Therapeutics (Adv. Funct. Mater. 4/2014).
- Published in:
- Advanced Functional Materials, 2014, v. 24, n. 4, p. 418, doi. 10.1002/adfm.201470021
- By:
- Publication type:
- Article
Synthesis and characterization of paclitaxel-imprinted nanoparticles for recognition and controlled release of an anticancer drug.
- Published in:
- Journal of Materials Science, 2014, v. 49, n. 18, p. 6343, doi. 10.1007/s10853-014-8360-7
- By:
- Publication type:
- Article
Water-soluble paclitaxel by conjugation to hyperbranched polyglycidols.
- Published in:
- Journal of Materials Science, 2013, v. 48, n. 15, p. 5163, doi. 10.1007/s10853-013-7302-0
- By:
- Publication type:
- Article